Monthly Archive: November 2011

Nov 30

3D Echocardiography: Reaffirming its Utility

Sameer Shrivastava, Vinay K Sharma Development of three dimensional echocardiography (3DE) is an exciting new development in the field of echocardiography. A vast corpus of literature has already proven utility of 3DE in routine clinical practice including of evaluation of cardiac pathologies and during interventional procedures. With more and more availability of 3D capable ultrasound …

Continue reading »

Nov 30

VVI Pacemakers Still Good For Indians

(Arun Ranganathan, Gnanavelu G, Geetha Subramanian, Arunachalam P, Venkatesan Sangareddi) Contrary to the popular belief, VVI pacemaker was not associated with worsening LV function and left atrial dimension in a Chennai based study at Madras Medical College. But there was a marginal deterioration in LV diastolic functional parameter. There was no significant   impact on the …

Continue reading »

Nov 30

The Heart Rhythm Society (HRS) 2011: Key Trials

DISCERN-AF: Asymptomatic atrial-fib recurrence clouds perception of ablation success  ALTITUDE: “Inappropriate” ICD shocks off the hook for mortality increase  PRELUDE: Inducibility in the EP lab a poor risk stratifier in Brugada syndrome  VT Ablation Study: High VT recurrence, mortality, and heart transplantation in VT ablation patients with very low EFs  CONFIRM: Ablating electrical rotors plus …

Continue reading »

Nov 30

Midwall Fibrosis in Aortic Stenosis

Myocardial fibrosis detected by late gadolinium enhancement on MRI is associated with adverse prognosis in ischemic and certain non-ischemic conditions. (J Am Coll Cardiol 2011; 58:1271).

Nov 30

Cardiac resynchronization therapy for functional mitral regurgitation

The impact of CRT on moderate to severe to severe mitral regurgitation was evaluated in a study of 98 patients.  Nearly half showed a significant improvement in mitral regurgitation (reduction by at least one grade). (Circulation 2011; 124:912).

Nov 30

Diastolic dysfunction carries poor prognosis

A study of 36,261 adults with normal LV ejection fraction followed for a mean of six years found that moderate or severe diastolic dysfunction is an independent risk factor for mortality (Arch Intern Med 2011; 171:1082).

Nov 29

Radial PCI feasible

Intervention through radial route has high success rate with very minimal that too minor complication. (Asymptomatic radial artery occlusion (3.2%), pain in the arm persistent for 4 weeks (0.4%), blackish discoloration of fore arm (2.4%), pseudo aneurysm (0.1%) and spasm (0.2%). A study by Dr P. V. Raghvava Sarma and Dr R. Murali Babu Rao …

Continue reading »

Nov 29

Medsacpe Top Ten Practice Changing News in Cardiology in the Year 2011

1. The results of the EMPHASIS-HF trial: showed that aldosterone antagonist eplerenone produced large reductions in both the risk for death and the risk for hospitalization compared with placebo in patients with systolic heart failure and mild symptoms. 2. New Data Show COURAGE Findings Are Not Being Implemented: In 2007, the landmark COURAGE study found …

Continue reading »

Nov 29

EuroPCR 2011

  RECLOSE 2-ACS: Poor clopidogrel responders with ACS face twofold risk of cardiac death  DISCOVER FLOW: Adding function to CTA with “noninvasive FFR” ups accuracy, may cut procedures  Renal denervation: can be the future  BASE-ACS: Could a bare-metal stent be “noninferior” to a leading DES?  DES meta-analysis: Less stent thrombosis with biodegradable vs permanent polymers …

Continue reading »

Nov 29

Cellular Phone Safe in the Shirt Pocket

Dr Devasia Tom and group from Kasturba Hospital, Manipal studied 100 healthy volunteers with normal baseline echocardiogram with a supine 12 lead ECG under three different conditions using the same mobile phone: no cellular phone (baseline), cellular phone in patient’s shirt pocket, but not ringing and a ringing cellular phone in patient’s shirt pocket. Heart …

Continue reading »

Older posts «